Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA approves new robotic surgery device

Senhance System backed for colorectal and gynaecological operations

US Food and Drug Administration (FDA)

US regulators have approved a new robotic surgery device for use in colorectal and gynaecological operations.

TransEnterix Surgical’s computer-assisted surgical Senhance System allows surgeons to sit at a console unit or cockpit that provides a 3-D high-definition view of the surgical field.

The three robotic arms they control are equipped with surgical instruments for visualisation and endoscopic manipulation of tissue, including through grasping and suturing.

Robotically-assisted surgical devices (RASDs), although not actually robots because they still require direct human control, can facilitate minimally invasive surgery and assist with complex tasks in confined areas of the body.

Binita Ashar, director of the Division of Surgical Devices in the FDA’s Center for Devices and Radiological Health, said: “Minimally invasive surgery helps reduce pain, scarring and recovery time after surgery.

“RASD technology is a specialised innovation in minimally invasive surgery designed to enhance the surgeon’s access and visualization within confined operative sites.”

RASD enables a surgeon to use computer and software technology to control and move surgical instruments through one or more tiny incisions in the patient’s body.

The FDA approved TransEnterix’s system for use in adults by trained physicians after the regulator concluded it was substantially equivalent for gynaecological and colorectal procedures to the da Vinci Si IS3000 device, which was launched in 2009 by Intuitive Surgical.

17th October 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics